Chinese medicine for treating coronary heart disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of coronary heart disease and traditional Chinese medicine, which is applied in the field of traditional Chinese medicine for the treatment of coronary heart disease, can solve the problems of large side effects, etc., and achieve the effects of convenient administration, prevention of acute attacks of lesions, and expansion of coronary blood vessels
Inactive Publication Date: 2012-05-02
苑芳胜
View PDF1 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although the chemical drugs act quickly, the side effects are relatively large during the treatment process, such as painkillers that can cause headaches, dizziness, reflex tachycardia, and orthostatic hypotension, etc.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0039] Example: From January 2008 to December 2010, 800 patients with coronary heart disease were treated successively, including 560 males and 240 females, aged 36-75 years, with a course of disease ranging from 2 days to 40 years.
[0040] 1. Diagnostic criteria
[0041] Refer to the 1999 American College of Cardiology (ACC) / American Heart Association (AHA) / American College of Physicians and American Society of Internal Medicine (ACP-ASIM) Joint Agreement on "Chronic Stability Diagnosis and Treatment Guidelines" in 2002 (ACC / AHA) "Unstable Guidelines for the diagnosis and treatment of non-ST-segment elevation myocardial infarction.
[0042] 2. Inclusion and exclusion criteria
[0043] Inclusion criteria: The patients in the test must meet the above diagnostic criteria and have the age of 36-75 years.
[0044] Exclusion criteria:
[0045] 1. Patients with severe hypertension, diabetes, malignant tumors, liver and kidney diseases, and thyroid diseases;
[0046] 2. Diabetic...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese medicine for treating coronary heart disease, which consists of the following raw materials by weight: 15 to 25g of suberect spatholobus stem,10 to 20g of Chinese angelica, 5 to 15g of grassleaf sweelflag rhizome, 5 to 15g of galangal, 10 to 25g of yanhusuo, 15 to 25g of common curculigo rhizome, 15 to 25g of epimedium herb, 15 to 25g of pilose asiabell root, 10 to 20g of dwarf lilyturf tuber, 5 to 15g of chinese magnoliavine fruit, 10 to 20g of ginger-processed pinellia tuber, 5 to 15g of costustoot, 5 to 15g of peach seed, 10 to 20g of Szechuan lovage rhizome, 10 to 25g of platycladi seed and 10 to 20g of kudzuvine root. The Chinese medicine integrates principles of promoting blood circulation and removing blood stasis, relieving pain aromatically, activating yang by removing obstruction of qi and blood circulation, promoting qi circulation and dissipating blood, tonifying middle-jiao and qi and warming kidney and strengthening yang of motherland medicine for treating chest obstruction, can fulfill the aims of promoting qi and blood circulation and relieving pain, and has important effect and significance when used for treating coronary heart disease, preventing acute lesion attack and stabilizing and delaying disease development, and the effective rate of treating coronary heart disease is over 75 percent.
Description
technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine for treating coronary heart disease, which belongs to the technical field of traditional Chinese medicine. Background technique [0002] Coronary heart disease is a common disease and frequently-occurring disease, which is the cardiomyopathy or clinical manifestation caused by coronary artery disease or coronary circulation changes. The most common is caused by atherosclerotic lesions, so it is also called coronary atherosclerotic heart disease, or ischemic heart disease, including, myocardial infarction, myocardial fibrosis and cardiac arrest or ventricular fibrillation caused sudden death, etc. Coronary heart disease is a common disease that seriously endangers people's health. [0003] For many years, Western medicine has mainly used drugs such as nitrates, beta blockers, calcium channel blockers, and anticoagulants to treat coronar...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more